Michael J Fox Foundation raises $1m on #GivingTuesday

News

Author: Parkinson's Life editorsPublished: 7 December 2017

Prep: Cook: Serves:

The Michael J Fox Foundation for Parkinson’s Research raised $1 million on #GivingTuesday – 28 November – as part of their #1Day1million fundraising campaign.

The charity had pledged to match-fund any donation up to the one million dollar mark, with 89 cents from every dollar spent at The Foundation going directly to research programmes.

In a statement, the organisation said: “We did it: thanks to your support and energy, we met our Giving Tuesday goal of raising $1 million in one day, to help speed a cure for Parkinson’s disease.

“Thousands of friends and followers shared their dedication to fuelling Parkinson’s research, championed our mission online, and most critically, donated. It was incredible to see the outpouring of support for the Parkinson’s community, demonstrating how together, we can – and we will – cure Parkinson’s disease.”

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

Globetrotting with Parkinson’s: ‘a wonderful world waiting to be explored’

Maura Ward shares her top tips for travelling with Parkinson’s

Parkinson’s in the news: March

A roundup of Parkinson’s news stories in March

How close are we to a Parkinson’s breakthrough? Three experts have their say

Renowned experts give their opinions on the next breakthrough

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Researchers have discovered that a molecule called BT13 could have potential to treat Parkinson’s. The study, conducted by scientists from the University of Helsinki, Finland, found that mice injected with the BT13 molecule had an increase in dopamine levels in the brain. Their findings also suggested that the molecule could lead to a new drug treatment to protect the brain cells that produce dopamine. Dopamine helps coordinate movement, but people with Parkinson’s have normally lost between 70 and 80% of the brain cells that produce the neurotransmitter when they are diagnosed with the condition. Professor David Dexter, Deputy Director of Research at Parkinson’s UK – which co-funded the study – said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms. “More research is needed to turn BT13 into a treatment to be tested in clinical trials, to…

Students develop wearable device to track Parkinson’s tremors

A wearable device has been developed to monitor Parkinson’s tremors and their severity through the tracking of body movements. The device – Tremor Tracker – was created by two students, Julie Gaudin and Elizabeth Hummel, at Louisiana Tech University, US, as part of a design class project. The students designed an algorithm using data recorded from volunteer participants at Rock Steady, a boxing programme for people with Parkinson’s. They then applied the algorithm to a GENEActiv, a wrist-worn device that has been scientifically validated for clinical research. Hummel, co-creator of the Tremor Tracker, said: “Through supervised machine learning, the device predicts whether a patient’s tremors are parkinsonian or non-parkinsonian, as well as the severity of these tremors. A quantitative analysis of parkinsonian tremors provides a more detailed disease state.”

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

Reawakening dormant neurons could help reverse Parkinson’s motor symptoms, researchers in South Korea have found. While Parkinson’s is typically believed to be caused by neuronal death, a new study – published in ‘Current Biology’ journal – suggests that dormant neurons could be another cause. After completing an animal test – which treated the subjects with two compounds that block dopamine-producing neurons from becoming dormant – the researchers found these neurons to be “awakened”, allowing them to resume dopamine production. The researchers hope that this will lead to a disease-modifying treatment, especially for people in the early stages of Parkinson’s. Hoon Ryu, a senior author of the study and researcher at KIST Brain Science Institute, South Korea, said: “This research refutes the common belief that there is no disease-modifying treatment for Parkinson’s due to its basis on neuronal cell death.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Michael J Fox Foundation raises $1m on #GivingTuesday

News

Author: Parkinson's Life editorsPublished: 7 December 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

Globetrotting with Parkinson’s: ‘a wonderful world waiting to be explored’

Global update

Parkinson’s in the news: March

Special reports

How close are we to a Parkinson’s breakthrough? Three experts have their say

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

Michael J Fox Foundation raises $1m on #GivingTuesday

News

Author: Parkinson's Life editorsPublished: 7 December 2017

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

Globetrotting with Parkinson’s: ‘a wonderful world waiting to be explored’

Global update

Parkinson’s in the news: March

Special reports

How close are we to a Parkinson’s breakthrough? Three experts have their say

‘Dopamine-boosting’ BT13 molecule could be used to slow Parkinson’s

Students develop wearable device to track Parkinson’s tremors

Can awakening dormant neurons reverse Parkinson’s motor symptoms?

{title}

Subscribe

Sign in